Research Article

Relationship between Plasma Lipoprotein-Associated Phospholipase A2 Concentrations and Apolipoprotein in Stable Coronary Artery Disease Patients

Table 1

Baseline features of the study population.

Non-CAD ()Stable CAD ()

Sex, M/F131/147148/1430.373
Age, y<0.001
Hypertension, (%)191 (68.7)232 (79.7)0.003
Diabetes, (%)49 (17.6)79 (27.1)0.014
Smoking, (%)103 (37.1)158 (54.3)0.096
BMI, kg/m20.124
Alcohol intake, (%)133(47.8)149(51.2)0.324
Physical inactivity, (%)121(43.5)134(46.0)0.368
DEI/day, (kcal/d)0.238
PSS score0.274
TC, mmol/L0.022
TG, mmol/L0.143
LDL, mmol/L0.163
HDL, mmol/L0.626
ApoA1, g/L0.312
ApoB, g/L0.370
ApoB/ApoA10.050
TB, umol/L0.521
DB, umol/L0.614
ALT, U/L0.767
AST, U/L0.663
Albumin, g/L0.061
Scr, umol/L0.966
BUN, mmol/L0.522
WBC, 10^9/L0.633
RBC, 10^12/L0.286
LP-PLA2, ng/mL<0.001

WBC: white blood cell; BMI: body mass index; DEI: dietary energy intake; PSS: perceived stress scale; RBC: red blood cell; TC: total cholesterol; TG: triglyceride; LDL: low-density lipoprotein; HDL: high-density lipoprotein; Scr: serum creatinine; BUN: blood urea nitrogen; TB: total bilirubin; DB: direct bilirubin.